Given the reciprocal interaction of inflammasome and NET formation and based on the current findings, targeting NET formation may constitute an alternative approach to restrict sterile inflammation in DKD and possibly other NET-associated vasculopathies and diseases, without interfering directly with the Nlrp3 inflammasome. The gene discussed is NLRP3; the disease is vascular disorder.